Xconomy: cancer News, Articles and Opinions

“cancer” Archives

Entry	Author	Date	Location
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston	Angela Shah	03/18/19	Texas
Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments	Sarah de Crescenzo	03/15/19	San Diego
CesiumAstro, MAP Health, StoryFit, Hatch Pitch & More Texas Tech	Angela Shah	03/15/19	Texas
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More	Frank Vinluan	03/15/19	National
Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work	Sarah de Crescenzo	03/06/19	San Diego
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy	Frank Vinluan	03/04/19	Raleigh Durham
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington	Frank Vinluan	02/27/19	New York
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO	David Holley	02/26/19	Texas
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer	Ben Fidler	02/26/19	New York
FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns	Frank Vinluan	02/22/19	Boston
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More	Frank Vinluan	02/22/19	National
Merck Scooping Up Cancer Drug Developer Immune Design for $300M	Frank Vinluan	02/21/19	New York
Blaze Bio Raises $5M to Help Surgeons See Tumors From Healthy Tissue	Jeff Buchanan	02/20/19	Seattle
Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy	Angela Shah	02/20/19	Texas
Funds for Richard’s Rainwater, New CPRIT Executive, & More TX Tech	Angela Shah	02/15/19	Texas
Bayer Snaps Up Rights to Two Cancer Drugs from Lilly’s $8B Loxo Deal	Frank Vinluan	02/15/19	Indiana
TCR²’s IPO Raises $75M to Bring Cancer Cell Therapy to Solid Tumors	Frank Vinluan	02/14/19	Boston
AbbVie Joins Myeloma Race with $90M Deal for Rights to Teneobio Drug	Frank Vinluan	02/11/19	San Francisco
Genomenon Raises $2.5M, Plans to Increase Work with Pharma Customers	Sarah Schmid Stevenson	02/08/19	Detroit Ann Arbor
Harpoon’s IPO Spears $76M as Prostate Cancer Drug Continues Testing	Frank Vinluan	02/07/19	San Francisco
Hypergiant in Space, Celltex & Saudi, Siete Foods’ $90M, & More TX Tech	Angela Shah	02/07/19	Texas
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M	Sarah de Crescenzo	02/06/19	San Diego
Bolt Bio Bags $54M for Drugs that Turn the Heat Up on “Cold” Tumors	Frank Vinluan	02/05/19	San Francisco
Cancer Cures and the Importance of Communicating Responsibly	Carin Canale-Theakston	02/04/19	San Diego
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More	Frank Vinluan	02/01/19	National
Aduro Biotech Slashes Staff 37%, Turns Focus to Lead Cancer Drugs	Frank Vinluan	01/30/19	San Francisco
Dewpoint Debuts with $60M to Target Protein Droplets Linked to Disease	Corie Lok	01/30/19	Boston
In Another Lung Cancer Setback, Bristol Yanks FDA App For Drug Combo	Ben Fidler	01/24/19	New York
Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo	Frank Vinluan	01/18/19	Indiana
Despite Buyout, Celgene Dealmaking Rolls On With Kyn, Obsidian Tie-Ups	Corie Lok	01/18/19	Boston
Page 1 of 76	next page »